← Signals · Healthcare · TSXV
$TLT
Theralase Technologies Inc.
Signal as of August 18, 2026  ·  90-day rolling window  ·  Medical Equipment & Supplies
Confluence Score
39
out of 100  ·  Full breakdown →
Score delayed 7 days on Free  ·  See today's score — Analyst →
Signals scoring 20–39 have historically hit 40% of the time (avg +4.5% over 90 days, 537 backtested signals). Methodology →
🔒 Risk monitoring — insider-selling & reversal warnings (Analyst)
2 open-market buys  ·  1 unique buyer  ·  $10K total Lobbying: 0 regs  ·  Contracts: 0 wins
Confluence Score
39
Unlock breakdown →
Insider Activity (90d)
2
1 buyer  ·  $10K  ·  open-market only
Current Price
$0.19
CAD  ·  5-min cache
Market Cap
$49M
CAD  ·  TMX
Lobbying & Contracts
None
0 regs  ·  0 contracts
Healthcare on Form55: 43% hit rate · -5.4% alpha vs XIU.TO · 21 closed signals Track Record →
★
Signal Analyst
The Confluence Score and insider trade feed above are free. Signal Analyst adds the full component breakdown, lobbying registrations, and contract wins — plus alerts when this company's signal moves, so you don't have to keep checking back.
Monitor — CAD $29/mo
Price Chart
12 months daily  ·  TSXV:TLT
Insider Transactions
90-day window  ·  no filings

No insider transactions in the last 90 days.

Score Breakdown
Signal Analyst  ·  $29/mo
Component Points Max Detail Weight
Conviction (unique buyers)  ✓ FREE PREVIEW 30 30 1 unique buyer (maximum conviction)
Buy/sell ratio 20 40% buys (2B / 3S)
Dollar value 25 $10K
Lobbying activity 15 None
Contract wins 10 None
Insider track record 10 No track record data
Private placements 8 None
Confluence bonus 10 None
Cluster timing (velocity) 10 No coordinated buying cluster detected
Buy/sell reversal pattern 8 No buy/sell reversal pattern
Total 39 100
Unlock Component Detail — CAD $29/mo
Lobbying Registrations
OCL active  ·  none found
No active OCL lobbying registrations in the last 90 days. Analyst plan →
Government Contract Wins
90-day window  ·  none found
No government contract wins in the last 90 days. Analyst plan →
Private Placements
12 months  ·  Signal Analyst  ·  $29/mo
Private placement history, deal size, and lock-up expiry tracking. Analyst plan →
Indigenous Consultation
no records on file

No Indigenous consultation records on file for TLT.

SEDAR+ Filings
official filing registry
Form55 monitors SEDAR+ filing alerts and newswire announcements for Technical Reports and material changes. Search SEDAR+ →
Short Interest
CIRO  ·  Aug 15, 2026
Shares short
5,097,704
Net change
+5,036,062 (+8169.9%)
Short interest rose 8170% since the prior report.
History
Aug 15: 5,097,704
Jul 31: 61,642
Jul 15: 128,284
Jun 30: 20,302
Jun 15: 9,443
May 31: 63,531
Aggregate short position from CIRO's Consolidated Short Position Report (published twice monthly).
Clinical Trials
ClinicalTrials.gov  ·  2 trials
Phase Status Trial Updated
P2 Recruiting Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolera Nov 2025
P1 Completed Intravesical Photodynamic Therapy (PDT) in BCG Refractory High-Risk No Aug 2018
Trials where this company is the lead sponsor (ClinicalTrials.gov). Phase advances, completions and terminations are material catalysts for clinical-stage companies — not investment advice.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.